FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
This Quarter Return
+13.67%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
AUM
$247M
AUM Growth
+$247M
Cap. Flow
+$12M
Cap. Flow %
4.88%
Top 10 Hldgs %
99.51%
Holding
17
New
4
Increased
1
Reduced
4
Closed
5
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AIMT
1
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$94.7M 38.39%
3,820,462
-172,055
-4% -$4.27M
AERI
2
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$81.3M 32.95%
1,672,714
EPZM
3
DELISTED
Epizyme, Inc
EPZM
$29.4M 11.92%
1,543,108
+58,368
+4% +$1.11M
ALDR
4
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$12.8M 5.18%
1,043,832
INSM icon
5
Insmed
INSM
$30.7B
$9.36M 3.8%
+300,000
New +$9.36M
XLRN
6
DELISTED
Acceleron Pharma Inc.
XLRN
$9.13M 3.7%
+244,756
New +$9.13M
JUNO
7
DELISTED
Juno Therapeutics, Inc.
JUNO
$4.04M 1.64%
+90,000
New +$4.04M
JNCE
8
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.87M 0.76%
119,912
DERM
9
DELISTED
Dermira, Inc.
DERM
$1.58M 0.64%
58,624
-76,670
-57% -$2.07M
LOXO
10
DELISTED
Loxo Oncology, Inc
LOXO
$1.32M 0.53%
+14,300
New +$1.32M
OREX
11
DELISTED
Orexigen Therapeutics, Inc.
OREX
$1.11M 0.45%
523,132
-78,881
-13% -$167K
LRMR icon
12
Larimar Therapeutics
LRMR
$322M
$108K 0.04%
30,775
-88,920
-74% -$312K
AKBA icon
13
Akebia Therapeutics
AKBA
$822M
-50,000
Closed -$719K
ARDX icon
14
Ardelyx
ARDX
$1.54B
-37,500
Closed -$191K
SGMO icon
15
Sangamo Therapeutics
SGMO
$161M
-46,000
Closed -$405K
NSTG
16
DELISTED
NanoString Technologies, Inc.
NSTG
-254,015
Closed -$4.2M
BLCM
17
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-50,559
Closed -$591K